Artículo

Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Type 1 diabetes (T1D) is a disease caused by the destruction of the β cells of the pancreas by activated T cells. Dendritic cells (BC) are the APC that initiate the T cell response that triggers T1D. However, DC also participate in T cell tolerance, and genetic engineering of DC to modulate T cell immunity is an area of active research. Galectin-1 (gal-1) is an endogenous lectin with regulatory effects on activated T cells including induction of apoptosis and down-regulation of the Th1 response, characteristics that make gal-1 an ideal transgene to transduce DC to treat T1D. We engineered bone marrow-derived DC to synthesize transgenic gal-1 (gal-1-DC) and tested their potential to prevent T1D through their regulatory effects on activated T cells. NOD-derived gal-1-DC triggered rapid apoptosis of diabetogenic BDC2.5 TCR-transgenic CD4+ T cells by TCR-dependent and -independent mechanisms. Intravenously administered gal-1-DC trafficked to pancreatic lymph nodes and spleen and delayed onset of diabetes and insulitis in the NODrag1 -/- lymphocyte adoptive transfer model. The therapeutic effect of gal-1-DC was accompanied by increased percentage of apoptotic T cells and reduced number of IFN-γ-secreting CD4+ T cells in pancreatic lymph nodes. Treatment with gal-1-DC inhibited proliferation and secretion of IFN-γ of T cells in response to β cell Ag. Unlike other DC-based approaches to modulate T cell immunity, the use of the regulatory properties of gal-1-DC on activated T cells might help to delete β cell-reactive T cells at early stages of the disease when the diabetogenic T cells are already activated. Copyright © 2005 by The American Association of Immunologists, Inc.

Registro:

Documento: Artículo
Título:Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice
Autor:Perone, M.J.; Bertera, S.; Tawadrous, Z.S.; Shufesky, W.J.; Piganelli, J.D.; Baum, L.G.; Trucco, M.; Morelli, A.E.
Filiación:Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, United States
Department of Pathology, School of Medicine, University of California, Los Angeles, CA 90095, United States
Laboratorio de Fisiologia Y Biologia Molecular, Universidad de Buenos Aires, Ciudad Universitaria-Pabellon II, Buenos Aires 1428, Argentina
Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213-2582, United States
Palabras clave:galectin 1; gamma interferon; adoptive transfer; animal cell; animal experiment; animal model; animal tissue; antigen presenting cell; apoptosis; article; autoimmune disease; CD4+ T lymphocyte; cellular immunity; controlled study; cytokine release; dendritic cell; disease model; down regulation; female; GAL1 gene; genetic engineering; insulin dependent diabetes mellitus; insulitis; lymph node; lymphocyte proliferation; mouse; nonhuman; pancreas islet beta cell; priority journal; protein function; protein synthesis; spleen; T lymphocyte activation; Th1 cell; transgene
Año:2006
Volumen:177
Número:8
Página de inicio:5278
Página de fin:5289
DOI: http://dx.doi.org/10.4049/jimmunol.177.8.5278
Título revista:Journal of Immunology
Título revista abreviado:J. Immunol.
ISSN:00221767
CODEN:JOIMA
CAS:galectin 1, 258495-34-0; gamma interferon, 82115-62-6
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_00221767_v177_n8_p5278_Perone.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00221767_v177_n8_p5278_Perone

Referencias:

  • Atkinson, M.A., Maclaren, N.K., The pathogenesis of insulin-dependent diabetes mellitus (1994) N. Engl. J. Med., 331, pp. 1428-1436
  • Perillo, N.L., Marcus, M.E., Baum, L.G., Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death (1998) J. Mol. Med., 76, pp. 402-412
  • Rabinovich, G.A., Baum, L.G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.T., Iacobelli, S., Galectins and their ligands: Amplifiers, silencers or turners of the inflammatory response (2002) Trends Immunol., 23, pp. 313-320
  • Perillo, N.L., Pace, K.E., Seilhamer, J.J., Baum, L.G., Apoptosis of T cells mediated by galectin-1 (1995) Nature, 378, pp. 736-739
  • Perillo, N.L., Uittenbogaart, C.H., Nguyen, J.T., Baum, L.G., Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes (1997) J. Exp. Med., 185, pp. 1851-1858
  • Rabinovich, G.A., Daly, G., Dreja, H., Tailor, H., Riera, C.M., Hirabayashi, J., Chernajovsky, Y., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J. Exp. Med., 190, pp. 385-398
  • Poirier, F., Timmons, P.M., Chan, C.-T.J., Guenet, J.-L., Rigby, P.W.J., Expression of the L14 lectin during mouse embryogenesis suggests multiple roles during pre- and post-implantation development (1992) Development, 115, pp. 143-155
  • Dettin, L., Rubinstein, N., Aoki, A., Rabinovich, G.A., Maldonado, C.A., Regulated expression and ultrastructural localization of Galectin-1, a proapoptotic β-galactoside-binding lectin, during spermatogenesis in rat testis (2002) Biol. Reprod., 68, pp. 51-59
  • Joubert, R., Kuchler, S., Zanetta, J.P., Bladier, D., Avellana-Adalid, V., Caron, M., Doinel, C., Vincendon, G., Immunohistochemical localization of a β-galactoside-binding lectin in the rat central nervous system. I. Light- and electron-microscopical studies on developing cerebral cortex and corpus callosum (1989) Dev. Neurosci., 11, pp. 397-413
  • Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251
  • McHugh, R.S., Whitters, M.J., Piccirillo, C.A., Young, D.A., Shevach, E.M., Collins, M., Byrne, M.C., CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor (2002) Immunity, 16, pp. 311-323
  • Offner, H., Celnik, B., Bringman, T.S., Casentini-Borocz, D., Nedwin, G.E., Vandenbark, A.A., Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis (1990) J. Neuroimmunol., 28, pp. 177-184
  • Santucci, L., Fiorucci, S., Rubinstein, N., Mencarelli, A., Palazzetti, B., Federici, B., Rabinovich, G.A., Morelli, A., Galectin-1 suppresses experimental colitis in mice (2003) Gastroenterology, 24, pp. 1381-1394
  • Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity (1998) Nature, 392, pp. 245-252
  • Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., Palucka, K., Immunobiology of dendritic cells (2000) Annu. Rev. Immunol., 18, pp. 767-811
  • Ludewig, B., Odermatt, B., Landmann, S., Hengartner, H., Zinkernagel, R.M., Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue (1998) J. Exp. Med., 188, pp. 1493-1501
  • Jonuleit, H., Schmitt, E., Steinbrink, K., Enk, A.H., Dendritic cells as a tool to induce anergic and regulatory T cells (2001) Trends Immunol., 22, pp. 394-400
  • Steinman, R.M., Hawiger, D., Nussenzweig, M.C., Tolerogenic dendritic cells (2003) Annu. Rev. Immunol., 21, pp. 685-711
  • Thiessen, S., Serra, P., Amrani, A., Verdaguer, J., Santamaria, P., T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes (2002) Diabetes, 51, pp. 325-338
  • Morelli, A.E., Thomson, A.W., Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction (2003) Immunol. Rev., 196, pp. 125-146
  • Hackstein, H., Thomson, A.W., Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs (2004) Nat. Rev. Immunol., 4, pp. 24-34
  • Feili-Hariri, M., Xin, D., Alber, S.M., Watkins, S.C., Salter, R.D., Morel, P.A., Immunotherapy of NOD mice with bone marrow-derived dendritic cells (1999) Diabetes, 48, pp. 2300-2308
  • Machen, J., Harnaha, J., Lakomy, R., Styche, A., Trucco, M., Giannoukakis, N., Antisense oligonucleotides down-regulate costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells (2004) J. Immunol., 173, pp. 4331-4341
  • Santucci, L., Fiorucci, S., Cammilleri, F., Servillo, G., Federici, B., Morelli, A., Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice (2000) Hepatology, 31, pp. 399-406
  • Baum, L.G., Blackall, D.P., Arias-Magallano, S., Nanigian, D., Uh, S.Y., Browne, J.M., Hoffmann, D., Baldwin, G.C., Amelioration of graft versus host disease by galectin-1 (2003) Clin. Immunol., 109, pp. 295-307
  • Pace, K.E., Hahn, H.P., Baum, L.G., Preparation of recombinant human galetin-1 and use in T cell assays (2003) Methods Enzymol., 363, pp. 499-518
  • Morelli, A.E., Zahorchak, A.F., Larregina, A.T., Colvin, B.L., Logar, A.J., Takayama, T., Falo, L.D., Thomson, A.W., Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation (2001) Blood, 98, pp. 1512-1523
  • Katz, J.D., Wang, B., Haskins, K., Benoist, C., Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis (1993) Cell, 74, pp. 1089-1100
  • Yoshida, K., Martin, T., Yamamoto, K., Dobbs, C., Munz, C., Kamikawaji, N., Nakano, N., Kikutani, H., Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones (2002) Int. Immunol., 12, pp. 1439-1447
  • Piganelli, J.D., Flores, S.C., Cruz, C., Koepp, J., Batinic-Haberle, I., Crapo, J., Day, B., Haskins, K., A metalloprophyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone (2002) Diabetes, 51, pp. 347-355
  • Kurrer, M.O., Pakala, S., Hanson, H.L., Katz, J.D., β cell apoptosis in T cell-mediated autoimmune diabetes (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 213-218
  • Christianson, S.W., Shultz, L.D., Leiter, E.H., Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NOD-Thy-1a donors (1993) Diabetes, 42, pp. 44-55
  • Rohane, P.W., Shimada, A., Kim, D.T., Edwards, C.T., Charlton, B., Shultz, L.D., Fathman, G., Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice (1995) Diabetes, 44, pp. 550-554
  • Bertera, S., Crawford, M.L., Alexander, A.M., Papworth, G.D., Watkins, S.C., Robbins, P.D., Trucco, M., Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes (2003) Diabetes, 52, pp. 387-393
  • Matarese, G., Sanna, V., Lechler, R.I., Sarvetnick, N., Fontana, S., Zappacosta, S., La Cava, A., Leptin accelerates autoimmune diabetes in female NOD mice (2002) Diabetes, 51, pp. 1356-1361
  • Perone, M.J., Larregina, A.T., Shufesky, W.J., Papworth, G.D., Sullivan, M.L.G., Zahorchak, A.F., Beer Stolz, D., Morelli, A.E., Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells (2006) J. Immunol., 176, pp. 7207-7220
  • He, J., Baum, L.G., Presentation of galectin-1 by extracellular matrix triggers T cell death (2004) J. Biol. Chem., 279, pp. 4705-4712
  • Morelli, A.E., Larregina, A.T., Ganster, R.W., Zahorchack, A.F., Plowey, J.M., Takayama, T., Logar, A., Thomson, A.W., Recombinant adenoviral induces maturation of dendritic cells via an NF-κB dependent pathway (2000) J. Virol., 74, pp. 9617-9628
  • Levroney, E.L., Aguilar, H.C., Fulcher, J.A., Kohatsu, L., Pace, K.E., Pang, M., Gurney, K.B., Lee, B., Novel innate immune functions for galectin-1: Galectin-1 inhibits cell fusion by Nipah Virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines (2005) J. Immunol., 175, pp. 413-420
  • Fulcher, J.A., Hashimi, S.T., Levroney, E.L., Pang, M., Gurney, K.B., Baum, L.G., Lee, B., Galectin-1 matured human monocyte-derived dendritic cells have enhanced migration through extracellular martrix (2006) J. Immunol., 177, pp. 216-226
  • Haskins, K., McDuffie, M., Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone (1990) Science, 249, pp. 1433-1436
  • Atkinson, M.A., Maclaren, N.K., Islet cell autoantigens in insulin-dependent diabetes (1993) J. Clin. Invest., 92, pp. 1608-1616
  • Dias-Baruffi, M., Zhu, H., Cho, M., Karmakar, S., McEver, R.P., Cummings, R.D., Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis (2003) J. Biol. Chem., 278, pp. 41282-41293
  • Karmakar, S., Cummings, R.D., McEver, R.P., Contributions of Ca2+ to galectin-1-induced exposure of phosphatidylserine on activated neutrophils (2005) J. Biol. Chem., 280, pp. 28623-28631
  • Roep, B.O., De Vries, R.R., T-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus (1992) Eur J. Clin. Invest., 22, pp. 697-711
  • Cooper, D.N.W., Massa, S.M., Barondes, S.H., Endogenous muscle lectin inhibits myoblast adhesion to laminin (1991) J. Cell Biol., 115, pp. 1437-1448
  • Tarbell, K.V., Yamazaki, S., Olson, K., Toy, P., Steinman, R.M., CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes (2004) J. Exp. Med., 199, pp. 1467-1477
  • Höglund, P., Mintern, J., Waltzinger, C., Heath, W., Benoist, C., Mathis, D., Initiation of autoimmune diabetes by developmentally regulated presentation of islet cells antigens in the pancreatic lymph nodes (1999) J. Exp. Med., 189, pp. 331-339
  • Tisch, R., Yang, X.D., Singer, S.M., Liblau, R.S., Fluger, L., McDevitt, H.O., Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice (1993) Nature, 366, pp. 72-75
  • Chao, C.C., Sytwu, H.K., Chen, E.L., Toma, J., McDevitt, H.O., The role of MHC class II molecules in susceptibility of type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 9299-9304
  • Katz, J.D., Benoist, C., Mathis, D., T helper cell subsets in insulin-dependent diabetes (1995) Science, 268, pp. 1185-1188
  • Gepts, W., Pathologic anatomy of the pancreas in juvenile diabetes mellitus (1965) Diabetes, 14, pp. 619-633
  • Roep, B.O., Kallan, A.A., De Vries, R.R., β-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient: A putative mechanism of T-cell-mediated autoimmune islet cell destruction (1992) Diabetes, 41, pp. 1380-1384
  • Roep, B.O., T-cell responses to autoantigens in IDDM: The search for the Holy Grail (1996) Diabetes, 45, pp. 1147-1156
  • Stiller, C.R., Dupre, J., Gent, M., Jenner, M.R., Keown, P.A., Laupacis, A., Martell, R., Wolfe, B.M., Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset (1984) Science, 223, pp. 1362-1367
  • Bougneres, P.F., Carel, J.C., Castano, L., Boitard, C., Gardin, J.P., Landais, P., Hors, J., Bach, J.F., Factors associated with early remission of type I diabetes in children treated with cyclosporine (1988) N. Engl. J. Med., 318, pp. 663-670
  • Lampeter, E.F., Homberg, M., Quabeck, K., Schaefer, U.W., Wernet, P., Bertrams, J., Grosse-Wilde, H., Kolb, H., Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation (1993) Lancet, 341, pp. 1243-1244
  • Wicker, L.S., Miller, B.J., Mullen, Y., Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice (1986) Diabetes, 35, pp. 855-860
  • Bendelac, A., Carnaud, C., Boitard, C., Bach, J.F., Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and LyT-2+ T cells (1987) J. Exp. Med., 166, pp. 823-832
  • Peterson, J.D., Haskins, K., Transfer of diabetes in the NOD-scid mouse by CD4 T cell clones: Differential requirement for CD8 T cells (1996) Diabetes, 45, pp. 328-336
  • Ogawa, M., Maruyama, T., Hasegawa, T., Kanaya, T., Kobayashi, F., Tochino, Y., Uda, H., The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetic (NOD) mice (1985) Biomed. Res., 6, p. 103
  • Ikehara, S., Ohtsuki, H., Good, R.A., Asamoto, H., Nakamura, T., Sekita, K., Muso, E., Kuzuya, H., Prevention of type 1 diabetes in NOD mice by allogeneic bone marrow transplantation (1985) Proc. Natl. Acad. Sci. USA, 82, pp. 7743-7747
  • Roep, B.O., Kallan, A.A., Duinkerken, G., Arden, S.D., Hutton, J.C., Braining, G.J., De Vries, R.R., T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM (1995) Diabetes, 44, pp. 278-283
  • Chang, J.C., Linarelli, L.G., Laxer, J.A., Froning, K.J., Caralli, L.L., Brostoff, S.W., Carlo, D.J., Insulin secretory-granule specific T cell clones in human IDDM (1995) J. Autoimmun., 8, pp. 221-234
  • Chung, C.D., Patel, V.P., Moran, M., Lewis, L.A., Micelli, M.C., Galectin-1 induces partial TcR ζ-chain phosphorylation and antagonizes processive TCR signal transduction (2000) J. Immunol., 165, pp. 3722-3729
  • Pace, K.E., Lee, C., Stewart, P.L., Baum, L.G., Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 (1999) J. Immunol., 163, pp. 3801-3811
  • Rabinovich, G.A., Alonso, C.R., Sotomayor, C.E., Durand, S., Bocco, J.L., Riera, C.M., Molecular mechanism implicated in galectin-1-induced apoptosis: Activation of the AP-1 transcription factor and downregulation of Bcl-2 (2000) Cell Death Differ., 7, pp. 747-753
  • Cho, M., Cummings, R.D., Galectin-1, a β-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization (1995) J. Biol. Chem., 270, pp. 5198-5206
  • Larregina, A.T., Morelli, A.E., Tkacheva, O., Erdos, G., Donahue, C., Watkins, S.C., Thomson, A.W., Falo Jr., L.D., Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation (2004) Blood, 103, pp. 811-819
  • Vespa, G.N.R., Lewis, L.A., Kozak, K.R., Moran, M., Nguyen, J.T., Baum, L.G., Miceli, M.C., Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation (1999) J. Immunol., 162, pp. 799-806
  • Feili-Hariri, M., Falkner, D.H., Morel, P.A., Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice (2002) Eur. J. Immunol., 32, pp. 2021-2030
  • Feili-Hariri, M., Falkner, D.H., Gambotto, A., Papworth, G.D., Watkins, S.C., Robbins, P.R., Morel, P.A., Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advance insulins (2003) Hum. Gene Ther., 14, pp. 13-23
  • Papaccio, G., Nicoletti, F., Pisanti, F.A., Bendtzen, K., Galdieri, M., Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells (2000) Endocrinology, 141, pp. 1500-1505
  • Morin, J., Faideau, B., Gagnerault, M.-C., Lepault, F., Boitard, C., Boudaly, S., Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice (2003) Clin. Exp. Immunol., 134, pp. 388-395
  • Steptoe, R.J., Ritchie, J.M., Jones, L.K., Harrison, L.C., Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells (2005) Diabetes, 54, pp. 434-442
  • Krueger, T., Wohlrab, U., Klucken, M., Schott, M., Seissler, J., Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells (2003) Diabetologia, 46, pp. 1357-1365
  • Clare-Salzler, M.J., Brooks, J., Chai, A., Van Herle, K., Anderson, C., Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer (1992) J. Clin. Invest., 90, pp. 741-748
  • Shinomiya, M., Fazle Akbar, S.M., Shinomiya, H., Onji, M., Transfer of dendritic cells (DC) ex vivo stimulated with interferon-γ (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice (1999) Clin. Exp. Immunol., 117, pp. 38-43
  • Ma, L., Qian, S., Liang, X., Wang, L., Woodward, J.E., Giannoukakis, N., Robbins, P.D., Lu, L., Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-κB activity (2003) Diabetes, 52, pp. 1976-1985
  • Wegmann, D.R., Gill, R.G., Norbury-Glaser, M., Schloot, N., Daniel, D., Analysis of the spontaneous T cell response to insulin in NOD mice (1994) J. Autoimmun., 7, pp. 833-843
  • Daaboul, J., Schatz, D., Overview of prevention and intervention trials for type 1 diabetes (2003) Rev. Endocr. Metab. Disord., 4, pp. 317-323

Citas:

---------- APA ----------
Perone, M.J., Bertera, S., Tawadrous, Z.S., Shufesky, W.J., Piganelli, J.D., Baum, L.G., Trucco, M.,..., Morelli, A.E. (2006) . Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. Journal of Immunology, 177(8), 5278-5289.
http://dx.doi.org/10.4049/jimmunol.177.8.5278
---------- CHICAGO ----------
Perone, M.J., Bertera, S., Tawadrous, Z.S., Shufesky, W.J., Piganelli, J.D., Baum, L.G., et al. "Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice" . Journal of Immunology 177, no. 8 (2006) : 5278-5289.
http://dx.doi.org/10.4049/jimmunol.177.8.5278
---------- MLA ----------
Perone, M.J., Bertera, S., Tawadrous, Z.S., Shufesky, W.J., Piganelli, J.D., Baum, L.G., et al. "Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice" . Journal of Immunology, vol. 177, no. 8, 2006, pp. 5278-5289.
http://dx.doi.org/10.4049/jimmunol.177.8.5278
---------- VANCOUVER ----------
Perone, M.J., Bertera, S., Tawadrous, Z.S., Shufesky, W.J., Piganelli, J.D., Baum, L.G., et al. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J. Immunol. 2006;177(8):5278-5289.
http://dx.doi.org/10.4049/jimmunol.177.8.5278